Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Alnodesertib | C18H24N6O2S | CID 145766632 - PubChem
Alnodesertib (ART0380) | ATR inhibitor | Probechem Biochemicals
Alnodesertib Wins FDA Fast Track Status in ATM-Negative Colorectal ...
FDA Grants Fast Track to Alnodesertib Combo for Metastatic Colorectal ...
Alnodesertib Receives FDA Fast Track Designation For ATM– Metastatic ...
FDA Grants Fast Track Designation to Alnodesertib Plus Irinotecan in ...
Artios Receives U.S. FDA Fast Track Designation for alnodesertib in ATM ...
Artios’ Alnodesertib Obtains the US FDA’s Fast Track Designation for ...
Can Alnodesertib Transform ATM-Negative Colorectal Cancer Care ...
alnodesertib (ATR inhibitor) - Artios Pharma
Artios Reports Randomized Phase 2a Study of Low Dose Alnodesertib Plus ...
Artios Pharma develops oncology assets, including alnodesertib for ...
Alnodesertib ( 同义词: ART0380 ) | CAS 2267316-76-5 | 永璨生物
Alisertib (MLN8237) | Aurora A inhibitor | Probechem Biochemicals
一半患者肿瘤显著缩小或完全消失！结直肠癌新药Alnodesertib获快速通道资格-出国看病-盛诺一家
Artios Pharma secures $115 million to expand clinical evaluation of ...
ART0380 (Alnodesertib) | ATM/ATR 抑制剂 | 现货供应 | 美国品牌 | 免费采购电话400-668-6834
Method for preparing Alisertib - Eureka | Patsnap
Alnodesertib(Alnodesertib) - 药物靶点：ATR_在研适应症：腺泡细胞癌，晚期癌症，晚期恶性实体瘤_专利_临床_研发
o-Desmethyl alisertib | C26H18ClFN4O4 | CID 136013912 - PubChem
Pipeline - Artios Pharma
ALISERTIB SODIUM
Acetic acid, bis(3-pyridylamino)-, ethyl ester | C14H16N4O2 | CID ...
ALISERTIB
Globally Approved EGFR Inhibitors: Insights into Their Syntheses ...
Discovery of ART0380, a Potent and Selective ATR Kinase Inhibitor ...
Organic Syntheses Procedure
Artios Pharma Ltd. (Artios Pharma Ltd.) - 药物管线_专利_临床试验_投融营收_最新药物 ...
FDA grants Fast Track designation to oral ART inhibitor for ATM ...
Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) Is Highly ...
Preclinical Synergistic Combination Therapy of Lurbinectedin with ...
ATR抑制剂抗肿瘤研究进展 Research Progress of ATR Inhibitors in Anti-Tumor
NEW3AL8110_05.jpg
Artios Pharma Appoints Michael T. Andriole as CEO and Director to ...
Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in ...
107215800-1679942540642-al.jpg?v=1682442001&w=1920&h=1080
FDA Grants Fast-Track Designation to Drug Combo for Colorectal Cancer
Classical aldose reductase inhibitor (ARIs) in recent years | Download ...
Chemical structures of synthetic aldose reductase inhibitors that have ...
ATM kinase inhibitor AZD0156 in combination with irinotecan and 5 ...
Improving the Solubility, Stability, and Bioavailability of Albendazole ...
108037664-1727091787025-gettyimages-2173177207-AFP_36GZ4AL.jpeg?v ...
NEW3AL8110_03.jpg
Molecular structures of breast cancer drugs. (a) Alpelisib. (b ...
Zeno is effective in preclinical pancreatic cancer models. NRG1 fusion ...
FDA Awards Fast Track Status to Novel Drug Combination for Colorectal
NEW3AL8110_04.jpg
Introductory Chapter: Pharmacognosy | IntechOpen
Admilparant « New Drug Approvals
VP1-001 « New Drug Approvals
Anthelmintics medicinal chemistry | PPTX
A review on mushrooms as a versatile therapeutic agent with emphasis on ...
Development of Novel Microwell-Based Spectrofluorimetry and High ...
FDA grants fast track designation to drug combo for colorectal cancer ...
Artios raises $115M Series D to accelerate first-in-class cancer ...
AI in Biotech: 2025 Trends, Discoveries, and Game-Changing Technologies
Frontiers | Unlocking the power of nanomedicine: the future of ...
Moon Surgical's Maestro System powered by NVIDIA Holoscan paves the way ...
These highlights do not include all the information needed to use ...
